Renal lithiasis. Biochemical changes in the follow-up;Litiasis renal. Modificaciones bioquímicas durante el seguimiento

Medicina

Volumn 66, Issue 3, 2006, Pages 201-205

  Spivacow, Francisco R ^a   Del Valle, Elisa E ^a   Zancheta, Jose R ^a  

^a Instituto de Investigaciones Metabolicas   (Argentina)

Author keywords

Biochemical changes; Follow up; Renal lithiasis

Indexed keywords

URIC ACID;

ADULT; ARTICLE; BIOCHEMISTRY; CONTROLLED STUDY; DIETARY INTAKE; FEMALE; FOLLOW UP; HUMAN; HYPEROXALURIA; HYPOCITRATURIA; HYPOMAGNESEMIA; IDIOPATHIC HYPERCALCIURIA; MAJOR CLINICAL STUDY; MALE; METABOLIC DISORDER; NEPHROLITHIASIS; RECURRENT DISEASE; UREMIA;

ADULT; CITRATES; FEMALE; FOLLOW-UP STUDIES; HUMANS; KIDNEY CALCULI; MALE;

EID: 33746168315     PISSN: 00257680     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (29)

1. del Valle EE, Spivacow FR, Bogado C, Zanchetta JR. Recurrencia de nefrolitiasis en pacientes con alteraciones metabólicas bajo tratamiento. Rev Nefrol Dialisis Transpl 1990; S: 58.
2. Yendt ER, Cohanim M. Prevention of calcium stones with thiazides. Kidney Int 1978; 13: 397-409.
3. Preminger GM, Harvey JA, Pak CYC. Comparative efficacy of "specific potassium citrate therapy vs conservative management in nephrolithiasis of mild-moderate severity. J Urol 1985; 134: 658-61.
4. Consensus Conference. Prevention and treatment of kidney stones. JAMA 1988; 260: 977-81.
5. del Valle EE, Spivacow FR, Zanchetta JR. Evaluación metabólica ante el primer episodio de litiasis renal. Medicina (Buenos Aires) 1995; 55: 69-74.
6. Smith CH. When should stone patient be evaluated? Medical Clinics of North America 1984; 68: 455-9.
7. Curhan GC. A 44 Year-Old woman with kidney stones. JAMA 2005; 293: 1107-14.
8. Mardis HK, Parks JH, Muller G, Ganzel K, Coe FL. Outcome of metabolic evaluation and medical treatment for calcium nephrolithiasis in a private urological practice. J Urol 2004; 171: 85-8.
9. Shekarriz B, Stoller ML. Metabolic evaluation of stone disease. Braz J Urol 2001; 27: 10-8.
10. del Valle EE, Spivacow FR, Zanchetta JR. Alteraciones metabólicas en 2612 pacientes litiásicos. Medicina (Buenos Aires) 1999; 59: 417-22.
11. Pak CYC, Peterson R, Sakhaee K, Fuller C, Preminger G, Reisch J. Correction of hypocitraturia and prevention of stone formation by combined thiazide and potassium citrate therapy in thiazide-unresponsive hypercalciuric nephrolithiasis. Am J Med 1985; 79: 284-8.
12. Pak CYC. Citrate and renal calculi: an update. Miner Electrolyte Metab 1994; 20: 371-7.
13. Goldfarb S. Dietary factors in the pathogenesis and prophylaxis of calcium nephrolithiasis. Kidney Int 1988; 34: 544-55.
14. Pak CYC. Citrate and Renal Calculi: new insights and future directions. Am J Kidney Dis 1991; 17: 420-5.
15. Curhan GC, Willett WC, Rimm EB, Stampfer MJ. A prospective study of dietary calcium and other nutrients and the risk of symptomatic kidney stones. N Engl J Med 1993; 328: 833-8.
16. Lemann J. Pathogenesis of idiopathic hypercalciuria and nephrolithiasis. In: Disorders of bone and mineral metabolism, edited by Fredric L Coe and Murray J Favus, New York: Raven Press Ltd, 1992; pp 685-706.
17. Muldowney FP, Freaney R, Moloney MF. Importance of dietary sodium in the hypercalciuria syndrome. Kidney Int 1982; 22: 292-6.
18. Coe FL, Moran E, Kavalich AG. The contribution of dietary purine over-consumption to hyperpuricosuria in calcium oxalate stone formers. J Chronic Dis 1976; 12: 793-800.
19. Pak CY, Tolentino R, Stewart A, Galosy RA. Enhancement of renal excretion of uric acid during long-term thjiazide therapy. Invest Urol 1978; 16: 191-3.
20. Weinman EJ, Eknoyan G, Suki WN. The influence of extracellular fluid volume on the tubular reabsorption of uric acid. J Clin Invest 1975; 55: 283-91.
21. Halabe A, Sperling O. Uric acid nephrolithiasis. Miner Electrolyte Metab 1994; 20: 424-31.
22. Shils ME. Experimental human magnesium depletion. Medicine (Baltimore) 1969; 48: 61-85.
23. Carney SL, Wong NLM, Quamme GA, Dirks JH. Effect of magnesium deficiency on renal magnesium and calcium transport in the rat. J Clin Invest 1981 65: 180-8.
24. Dai LJ, Friedman PA, Quamme GA. Mechanisms of amiloride stimulation of Mg2+ uptake in immortalized mouse distal convoluted tubule cells. Am J Physiol 1997; 272: F249-F256.
25. Ettinger B, Citron JT, Livermore B, Dolman LI. Chlorthalidone reduces calcium oxalate calculous recurrence but magnesium hydroxide does not. J Urol 1988; 139: 679-84.
26. Barclo P, Wuhl O, Servitge E, Rousaud A, Pak CY. Randomized double-blind study of potassium citrate in idiopathic hypocitraturic calcium nephrolithiasis. J Urol 1993; 150: 1761-4.
27. Levy FL, Adams-Huet B, Pak CYC. Ambulatory evaluation of nephrolithiasis. An Update of a 1980 Protocol. Am J Med 1995; 98: 50-9.
28. Coe FL, Parks JH, Asplin JR. The pathogenesis and treatment of kidney stones. N Engl J Med 1992; 327: 1142-52.
29. Weisinger JR, Bellorín-Font E. Experiencia Latino-Americana em Litiase Renal. Venezuela. En: Calculose renal. Fisiopatologia, Diagnóstico. Tratamiento. N Schor, I Pfeferman Heilberg (eds), Sao Paulo: Servier; 1995; pp 354-9.